NCT03115944Unknown不适用
A Multi-Center Pilot Study to Assess the Safety and Efficacy of the vShape Ultra UltraSpeed Handpiece for Abdomen Circumference Reduction
适应症
干预措施
试验速览
- 阶段
- 不适用
- 入组人数
- 21
- 试验地点
- 6
- 主要终点
- Average Circumference Reduction as Measured by Skin Fold and Photography
研究概览
简要总结
A Multi-Center Pilot Study to Assess the Safety and Efficacy of the VShape Ultra UltraSpeed Handpiece for Abdomen Circumference Reduction
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Signed informed consent to participate in the study.
- •Female and male subjects, between 18 and 45 years of age at the time of enrollment.
- •Fitzpatrick Skin Type I to VI.
- •Fat thickness of at least 1.5 cm in the treated area (measured by calibrated caliper).
- •BMI interval: BMI between 20 to 30 (normal to overweight, but not obese).
- •If female, not pregnant or lactating, must be either post-menopausal, surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment (i.e., oral contraceptives, contraceptive implant, barrier methods with spermicide or abstinence).
- •In addition, negative urine pregnancy test as tested before each treatment and at the last follow-up visit for women with childbearing potential (e.g., not menopausal).
- •General good health confirmed by medical history and skin examination of the treated area.
- •Willing to follow the treatment and follow-up schedule and post-treatment care instructions.
- •Willingness to refrain from a change in diet / exercise / medication regimen for the entire course of the study.
- •Willing to have photographs and images taken of the treated areas to be used, de-identified in evaluations, publications and presentations.
排除标准
- •History of hypertension, ischemic heart disease, valvular heart disease, congestive heart failure, pacemaker / defibrillator, abnormal aortic aneurism.
- •Known hyperlipidemia, diabetes mellitus, hepatitis, liver disease, HIV positive status, blood coagulopathy or excessive bleeding, autoimmune or connective tissue disease.
- •Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the areas to be treated, including presence of malignant or pre-malignant pigmented lesions.
- •Having any active electrical implant anywhere in the body, such as a pacemaker or an internal defibrillator.
- •Having a permanent implant in the treated area, such as metal plates or an injected chemical substance such as silicone.
- •Having undergone any other surgery in the treated areas within 12 months of treatment or during the study, including liposuction.
- •Previous body contouring procedures in the treatment area within 12 months.
- •History of skin disease in the treatment area; known tendency to form keloids or poor wound healing.
- •Suffering from significant skin conditions in the treatment areas or inflammatory skin conditions, including, but not limited to, open lacerations or abrasions and active cold sores or herpes sores prior to treatment (duration of resolution as per the Investigator's discretion) or during treatment course.
- •Skin lesions in the treatment area other than simple nevi on physical examination (e.g., atypical nevus, tattoo, abrasions), including depressed scars in the treatment area.
- •Very poor skin quality (i.e., severe laxity).
- •Abnormal wall diastasis or hernia on physical examination.
- •Abnormal kidney, liver or coagulation functions, abnormal lipid profile or blood count within the last 3 months.
- •Obesity (BMI above 30)
- •Childbirth within the last 12 months or breastfeeding women.
- •Any acute or chronic condition which, in the opinion of the Investigator may exclude the candidate / patient from entry into the study.
研究组 & 干预措施
UltraSpeed Treatment
Experimental
UltraSpeed ultrasound treatments
干预措施: Alma vShape Ultra (Device)
结局指标
主要结局
Average Circumference Reduction as Measured by Skin Fold and Photography
时间窗: 4 Treatments over 4 Weeks
Skin fold measure utilizes caliper and photography utilizes Galaxy medical camera with extrapolation of measuring dot. Last measurement taken 14 days after final treatment.
次要结局
未报告次要终点
研究者
研究点 (6)
Loading locations...
相似试验
已完成
不适用
The Purpose of This Study is to Evaluate Safety and Performance of the V-STRUT© Transpedicular Vertebral SystemVertebral Compression FractureNCT03580434Hyprevention9
已完成
不适用
Pilot Study of the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator CuffRotator Cuff TearNCT01767740Smith & Nephew, Inc.82
Unknown
不适用
HIFU Treatment of Benign Thyroid NodulesThyroid Nodule (Benign)NCT04233398Theraclion240
已完成
不适用
UltraShape Power for Abdominal Fat and Circumference ReductionExcess Abdominal FatNCT02748928Syneron Medical62
已完成
不适用
Pulsenmore ES Device, Efficacy and Safety AssessmentPerinatal CareNCT05329077PulseNmore188